Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer
Y. Horita
◽
M. Nishino
◽
S. Sugimoto
◽
A. Kida
◽
A. Mizukami
◽
...
2019 ◽
Vol 30
(1)
◽
pp. 98-104
◽
Yosuke Horita
◽
Michiko Nishino
◽
Saiho Sugimoto
◽
Akihiko Kida
◽
Atsuyoshi Mizukami
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. 4049-4049
Rui-hua Xu
◽
Ming-ming He
◽
Dong-sheng Zhang
◽
Feng Wang
◽
Ying Jin
Dongqiang Zeng
◽
Wangjun Liao
◽
Kyoung Mee Kim
◽
Min Shi
◽
Rui Zhou
◽
...
2018 ◽
Vol 109
(11)
◽
pp. 3575-3582
◽
Ming‐ming He
◽
Feng Wang
◽
Ying Jin
◽
Shu‐qiang Yuan
◽
Chao Ren
◽
...
2008 ◽
Vol 134
(9)
◽
pp. 929-936
◽
Xiaodong Zhu
◽
Jiin Leaw
◽
Weilie Gu
◽
Yiying Qian
◽
Hongyu Du
◽
...
Stacy Cowherd
◽
Susan Melin
◽
Steven Akman
◽
John Cole
◽
Julia Lawrence
2015 ◽
Vol 16
(5)
◽
pp. 678-683
◽
S Cowherd
◽
L D Miller
◽
S A Melin
◽
S Akman
◽
S Isom
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 1013-1013
◽
F. Dalenc
◽
M. Campone
◽
P. Hupperets
◽
R. O'Regan
◽
C. Manlius
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. e21021-e21021
◽
Y. Chi
◽
Z. Zheng
◽
A. Zhou
◽
L. Yang
◽
T. Qu
◽
...
2015 ◽
Vol 51
◽
pp. S432
◽
B. Kim
◽
K.W. Lee
◽
M.J. Kim
◽
H.S. Han
◽
Y.L. Park
◽
...